Restore Medical announces a successful First-in-Human

Restore Medical saw promising results in their First-in-Human clinical trial of ContraBand™, a breakthrough treatment for patients suffering from congestive heart failure (CHF).

This trial is a milestone achievement in proving Restore Medical’s minimally-invasive, catheter-delivered implants to be a both safe and effective means of treating the millions of people suffering from CHF. 

You can read more here.